¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

±Ù°ÅÁß½ÉÀÇ Çѹæó¹æ

ÃßõÇϱâ
ÀÇÇм­Àû À̹øÁÖ BEST
 

±Ù°ÅÁß½ÉÀÇ Çѹæó¹æ

ÀϺ»µ¿¾çÀÇÇÐȸEBM Ưº°À§¿øȸ,ÀϺ»µ¿¾çÀÇÇÐȸ °øÀú | ±ºÀÚÃâÆÇ»ç

Ãâ°£ÀÏ 2011³â 07¿ù 25ÀÏ

417ÂÊ



¡Ø Ã¥¼Ò°³

ÀϺ»µ¿¾çÀÇÇÐȸ°¡ 2002³â¿¡ 1Â÷·Î ÇѹæÄ¡·á(Evidence report)¸¦ ³»°í, 2007³âºÎÅÍ 2Â÷ ¸®Æ÷Æ® ÀÛ¾÷ÇÑ °Í°ú 2010³â 6¿ù 1ÀÏ, ³í¹®À» ´Ù½Ã Ãß°¡·Î °Ë»öÇÏ¿© Æò°¡ ÀÛ¾÷ÇÑ °ÍÀ» Çѱ¹¾î·Î ¹ø¿ªÇÑ °ÍÀÌ´Ù.


¡Ø ¸ñÂ÷

¸Ó¸®¸»
1 À̹øVersion¿¡´ëÇÏ¿© .......................................................................... ix
2 (»ç)ÀϺ»µ¿¾çÀÇÇÐȸEBM Ưº°À§¿øȸ±¸¼º............................................... xi
3 Executive Summary........................................................................... xiii

PART 1 / ÃÑ·Ð

1 º»ÇÁ·ÎÁ§Æ®Àǹè°æ l background ............................................................... 2
2 ¸ñÀû l purpose ......................................................................................... 3
3 ±¸Á¶È­ÃÊ·ÏÀÇÀÛ¼º°úÁ¤ l steps for development of structured abstracts .............. 3
4 ¼±Åá¤Á¦¿ÜµÈ³í¹®ÀÇ°³¿ä l included references and excluded references ............ 11
5 ´Ù¸¥ÇÁ·ÎÁ§Æ®¿ÍÀÇ°ü·Ã l relation to other projects.......................................... 14
6 ÀÌÇØ»óÃæÀÇ°ü·Ã»çÇ× l conflict of interests .................................................. 19
7 °¨»çÀǸ» l acknowledgement............................................................

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ±Ù°ÅÁß½ÉÀÇ Çѹæó¹æ""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ½±°Ô ÀÀ¿ëÇϴ ħ±¸Ä¡·áÇÐ
´ÙÀ½±Û Áúȯº° ÇѹæÄ¡·áÀÇ ½ÇÁ¦
¹øÈ£
Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
13510
[»ý¸í°úÇÐ] »ý¸í°úÇаú À§´ëÇÑ °úÇÐÀÚµé »ý¸íÀÇ ..
0 1,218 2020-12-04
13509
[»ý¸í°úÇÐ] ²ÉµéÀÌ ³ª¿¡°Ô µé·ÁÁØ À̾߱â 5 ³²³è..
0 529 2020-12-04
13508
[»ý¸í°úÇÐ] ¾µµ¥¾øÀÌ À¯ÀÍÇÑ ²ÜÀë ²Ü¹ú°ú °³¹Ì°³..
0 809 2020-12-04
13507
[³ú°úÇÐ] ¹ø¾Æ¿ô ÀÌ·Ð, »ç·Ê ¹× ´ëÀÀ Àü·«
0 766 2020-12-04
13506
[»ý¸í°úÇÐ] ¼öÀÇ»ç¿Í ¼öÀÇ´ë»ýÀ» À§ÇÑ ÀÇÇпë¾î ..
0 1,040 2020-12-04
13505
[ÀÇÇÐ] ¸öº¸±â
0 529 2020-12-04
13504
[°£È£ÇÐ] °£È£¸®´õ½Ê ¸®´õ·Î ¼ºÀåÇÏ´Â °£È£ÇÐ..
0 854 2020-12-04
13503
[°£È£ÇÐ] 2021 Win-Q °£È£Á¶¹«»ç ´Ü±â¿Ï¼º
1 705 2020-12-04
13502
[°£È£ÇÐ] 2021 CARE °£È£»ç ±¹°¡°í½Ã ÇհݳëÆ®
0 636 2020-12-04
13501
[°£È£ÇÐ] 2021 ½ÃÇèÁ÷Àü ¸¶¹«¸® °£È£»ç±¹°¡°í..
0 499 2020-12-04
13500
[°£È£ÇÐ] 2021 °£È£»ç ±¹°¡°í½Ã 5ÀÏ ¿Ï¼º ÆÄÀÌ..
0 713 2020-12-04
13499
[°£È£ÇÐ] 2021 °£È£»ç ±¹°¡°í½Ã Ãʴܱâ¿Ï¼º ÆÄ..
0 698 2020-12-04
13498
[°£È£ÇÐ] º¸°ÇÀǾà°ü°è¹ý±Ô °£È£»ç ±¹°¡½ÃÇè ..
0 723 2020-12-04
13497
[°£È£ÇÐ] ¼ºÀΰ£È£ÇÐ °£È£»ç ±¹°¡½ÃÇè ´ëºñ ¹®..
0 559 2020-12-04
13496
[¾àÇÐ] ¹é¾à°¨º° È¥¿ëÇϱ⠽¬¿î È«Äá »ý¾à 1..
0 502 2020-12-04
13495
[¾àÇÐ] ¾à»ç¹ý ÆÇ·ÊÁ¤¸® º¸°Ç°ü°èÀÚ¶ó¸é ²À..
1 784 2020-12-03
13494
[¾àÇÐ] 2021 Æĸ¶½´Æ¼Äýº ÀÎ ÄÚ¸®¾Æ Pharma..
0 642 2020-12-03
13493
[ÀÇÇÐ] ½ºÅ׵常 ÀÇÇпë¾î
0 643 2020-12-03
13492
[ÀÇÇÐ] ½±°Ô ¹è¿ì´Â ±Ù±Ù¸·ÅëÁõÁõÈıº TPIÄ¡..
0 974 2020-12-03
13491
[ÀÇÇÐ] Áö¹æ°£ÇÐ
0 555 2020-12-03
11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷